Taipei, Taiwan

Chuan-Lung Hsu

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.7

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
4 patents (USPTO):

Title: The Innovations of Chuan-Lung Hsu

Introduction

Chuan-Lung Hsu is a prominent inventor based in New Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies for cancer treatment. With a total of four patents to his name, Hsu's work is at the forefront of medical research.

Latest Patents

Hsu's latest patents include groundbreaking advancements in anti-human PD-L1 antibodies and their applications. One of his notable inventions is an anti-PD-L1 antibody that comprises specific heavy and light chain variable regions, which can be utilized in various therapeutic contexts. Another significant patent involves antibody-drug conjugates containing anti-Globo H antibodies, which are designed to treat cancer by delivering therapeutic agents directly to targeted cells. This immunoconjugate represents a promising approach to enhance the efficacy of cancer treatments.

Career Highlights

Throughout his career, Chuan-Lung Hsu has worked with esteemed organizations such as the Development Center for Biotechnology and Academia Sinica. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.

Collaborations

Hsu has collaborated with notable colleagues, including Cheng-Chou Yu and Shih-Rang Yang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chuan-Lung Hsu's contributions to biotechnology and his innovative patents highlight his role as a key figure in the fight against cancer. His work continues to inspire advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…